Goldman Sachs Group Inc Pulse Biosciences, Inc. Transaction History

Goldman Sachs Group Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$7.8 - $11.02 $95,206 - $134,510	12,206 New	12,206 $106,000
Q2 2023 May 14, 2024	SELL	$3.67 - $8.64 $6,950 - $16,364	-1,894 Reduced 15.56%	10,279 $73,000
Q2 2023 Aug 14, 2023	BUY	$3.67 - $8.64 $37,723 - $88,810	10,279 New	10,279 $73,000
Q2 2022 May 14, 2024	BUY	$1.48 - $4.28 $18,016 - $52,100	12,173 New	12,173 $19,000
Q2 2022 Aug 15, 2022	SELL	$1.48 - $4.28 $5,360 - $15,502	-3,622 Reduced 22.93%	12,173 $19,000
Q1 2022 May 16, 2022	BUY	$4.21 - $14.79 $13,779 - $48,407	3,273 Added 26.14%	15,795 $77,000
Q4 2021 Feb 14, 2022	BUY	$14.78 - $24.4 $975 - $1,610	66 Added 0.53%	12,522 $185,000
Q3 2021 Nov 10, 2021	BUY	$17.25 - $26.63 $214,866 - $331,703	12,456 New	12,456 $269,000

4.8M

138K

96.2K

Ticker PLSE
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 37,125,900
Market Cap $541M
Description
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.